Mycobacterium chelonae isolates among new and previously treated pulmonary tuberculosis patients in Basra Government, South of Iraq, and anti-tuberculosis drugs resistance

Objective: The purpose of this study is to estimate the frequency of Mycobacterium chelonae among tuberculosis suspected patients in Basra Governorate and to evaluate the antimicrobial susceptibility. Methods: After isolation of M. chelonae from 100 samples from patients admitted to the RPDC, smears...

Full description

Bibliographic Details
Main Author: Abdulameer Abdullah Al-Mussawi
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2015-01-01
Series:International Journal of Mycobacteriology
Subjects:
Online Access:http://www.ijmyco.org/article.asp?issn=2212-5531;year=2015;volume=4;issue=5;spage=147;epage=147;aulast=Al-Mussawi;type=0
_version_ 1819183135720472576
author Abdulameer Abdullah Al-Mussawi
author_facet Abdulameer Abdullah Al-Mussawi
author_sort Abdulameer Abdullah Al-Mussawi
collection DOAJ
description Objective: The purpose of this study is to estimate the frequency of Mycobacterium chelonae among tuberculosis suspected patients in Basra Governorate and to evaluate the antimicrobial susceptibility. Methods: After isolation of M. chelonae from 100 samples from patients admitted to the RPDC, smears were stained with the Ziehl Neelsen technique. Specimens were inoculated on Lowenstein Jensen medium. Identification to species level was achieved on the basis of the growth characteristics. Drug susceptibility was tested with antibiotics (Rifampicin, Isoniazid, Ethambutol, Pyrazinamide and Streptomycin) using proportional method. Results: From the 100 sputum samples among tuberculosis suspected patients, 16 samples (16%) were Non-tuberculosis mycobacterium (NTM), 4 (4%) were M. chelonae. Drug susceptibility results showed all isolates resistant to rifampicin, while one isolate showed intermediate resistance to ethambutol. Also, all isolates of M. chelonae were sensitive to pyrazinamide, isoniazid and streptomycin. Conclusion: The results of this study emphasize that M. chelonae presents with high frequency, especially among tuberculosis suspected patients, which requires confirmation on a follow-up visit, along with the examination of patterns of sensitivity, and it is an absolute necessity in addition to the approximate hour patients typically spend in health centers in Iraq.
first_indexed 2024-12-22T22:57:13Z
format Article
id doaj.art-df728d5f1d444dcd81bdc4dc601882f4
institution Directory Open Access Journal
issn 2212-5531
2212-554X
language English
last_indexed 2024-12-22T22:57:13Z
publishDate 2015-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series International Journal of Mycobacteriology
spelling doaj.art-df728d5f1d444dcd81bdc4dc601882f42022-12-21T18:09:48ZengWolters Kluwer Medknow PublicationsInternational Journal of Mycobacteriology2212-55312212-554X2015-01-0145147147Mycobacterium chelonae isolates among new and previously treated pulmonary tuberculosis patients in Basra Government, South of Iraq, and anti-tuberculosis drugs resistanceAbdulameer Abdullah Al-MussawiObjective: The purpose of this study is to estimate the frequency of Mycobacterium chelonae among tuberculosis suspected patients in Basra Governorate and to evaluate the antimicrobial susceptibility. Methods: After isolation of M. chelonae from 100 samples from patients admitted to the RPDC, smears were stained with the Ziehl Neelsen technique. Specimens were inoculated on Lowenstein Jensen medium. Identification to species level was achieved on the basis of the growth characteristics. Drug susceptibility was tested with antibiotics (Rifampicin, Isoniazid, Ethambutol, Pyrazinamide and Streptomycin) using proportional method. Results: From the 100 sputum samples among tuberculosis suspected patients, 16 samples (16%) were Non-tuberculosis mycobacterium (NTM), 4 (4%) were M. chelonae. Drug susceptibility results showed all isolates resistant to rifampicin, while one isolate showed intermediate resistance to ethambutol. Also, all isolates of M. chelonae were sensitive to pyrazinamide, isoniazid and streptomycin. Conclusion: The results of this study emphasize that M. chelonae presents with high frequency, especially among tuberculosis suspected patients, which requires confirmation on a follow-up visit, along with the examination of patterns of sensitivity, and it is an absolute necessity in addition to the approximate hour patients typically spend in health centers in Iraq.http://www.ijmyco.org/article.asp?issn=2212-5531;year=2015;volume=4;issue=5;spage=147;epage=147;aulast=Al-Mussawi;type=0Mycobacterium chelonaeNon-tuberculosis mycobacteriumTuberculosis patientsTBAntimicrobial susceptibility testing
spellingShingle Abdulameer Abdullah Al-Mussawi
Mycobacterium chelonae isolates among new and previously treated pulmonary tuberculosis patients in Basra Government, South of Iraq, and anti-tuberculosis drugs resistance
International Journal of Mycobacteriology
Mycobacterium chelonae
Non-tuberculosis mycobacterium
Tuberculosis patients
TB
Antimicrobial susceptibility testing
title Mycobacterium chelonae isolates among new and previously treated pulmonary tuberculosis patients in Basra Government, South of Iraq, and anti-tuberculosis drugs resistance
title_full Mycobacterium chelonae isolates among new and previously treated pulmonary tuberculosis patients in Basra Government, South of Iraq, and anti-tuberculosis drugs resistance
title_fullStr Mycobacterium chelonae isolates among new and previously treated pulmonary tuberculosis patients in Basra Government, South of Iraq, and anti-tuberculosis drugs resistance
title_full_unstemmed Mycobacterium chelonae isolates among new and previously treated pulmonary tuberculosis patients in Basra Government, South of Iraq, and anti-tuberculosis drugs resistance
title_short Mycobacterium chelonae isolates among new and previously treated pulmonary tuberculosis patients in Basra Government, South of Iraq, and anti-tuberculosis drugs resistance
title_sort mycobacterium chelonae isolates among new and previously treated pulmonary tuberculosis patients in basra government south of iraq and anti tuberculosis drugs resistance
topic Mycobacterium chelonae
Non-tuberculosis mycobacterium
Tuberculosis patients
TB
Antimicrobial susceptibility testing
url http://www.ijmyco.org/article.asp?issn=2212-5531;year=2015;volume=4;issue=5;spage=147;epage=147;aulast=Al-Mussawi;type=0
work_keys_str_mv AT abdulameerabdullahalmussawi mycobacteriumchelonaeisolatesamongnewandpreviouslytreatedpulmonarytuberculosispatientsinbasragovernmentsouthofiraqandantituberculosisdrugsresistance